Descartes-25
DC25-1A
Phase 1 small_molecule terminated
Quick answer
Descartes-25 for Multiple Myeloma is a Phase 1 program (small_molecule) at Cartesian Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Cartesian Therapeutics
- Indication
- Multiple Myeloma
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- terminated